Circulating Tumor Cells Could Be Cultured From A Breast Cancer Patient's Blood

Circulating Tumor Cells Could Be Cultured From A Breast Cancer Patient's Blood

Article
Current Medical News
Cancer & Benign Tumors
Contributed byMaulik P. Purohit MD MPHNov 03, 2015

QUT researchers are working with an internationally renowned tumour cell expert in a bid to revolutionise the future of personalised cancer medicine.

Professor Jean Paul Thiery, who developed the most successful method yet for culturing small numbers of cancer cells present in blood, is on a Visiting Researcher Fellowship at QUT's Institute of Health and Biomedical Innovation (IHBI), working with researchers looking at breast, prostate, lung and head and neck cancer.

His latest research found circulating tumour cells (CTCs) could be cultured from a breast cancer patient's blood with an 80 per cent rate, up from about 25 per cent in previous studies.

IHBI Professor in Breast Cancer Research Rik Thompson, who has spent almost 30 years researching breast cancer, said Professor Thiery's discovery represented a major advance towards tailoring cancer drugs to individual patients.

"This is a huge breakthrough that allows us, with Professor Thiery's guidance, to study the CTCs and check to see which drugs may work against the cells that are forming metastases," Professor Thompson said.

"The challenge is that metastasis is often a killer and can be different cancers from the primary. It is difficult to identify every metastasis deposit in the body, but the most aggressive cancer deposits will be represented in the blood and therefore picked up in Professor Thiery's culturing method.

"It means we can harvest these cancerous cells and test drugs on them in a lab, before they are tested on patients. This allows us to more quickly identify the most effective drugs for treatment."

Professor Thompson said translational cancer researchers were already looking at whether drugs could be repurposed to treat different types of cancer.

"For example, about 5 per cent of pancreatic cancers may share the same genetic pathway as seen in an aggressive type of breast cancer, for which very successful treatments are available," he said.

"And there is even the potential for drugs that treat other diseases to be useful in the fight against certain cancers.

"Professor Thiery's research helps us to better understand what is going on in the bodies of cancer patients and, through collaboration with researchers in other areas, how we can more effectively treat these patients."

Professor Thiery said CTC research was opening up "extraordinary opportunities" for more targeted, personalised care for cancer patients. 


The above post is a redistributed news release provided by Queensland University of Technology. Note: Materials may be edited for content and length. 

Disclaimer: DoveMed is not responsible for the adapted accuracy of news releases posted to DoveMed by contributing universities and institutions.

Was this article helpful

On the Article

Maulik P. Purohit MD MPH picture
Approved by

Maulik P. Purohit MD MPH

Assistant Medical Director, Medical Editorial Board, DoveMed Team

0 Comments

Please log in to post a comment.

Related Articles

Test Your Knowledge

Asked by users

Related Centers

Loading

Related Specialties

Loading card

Related Physicians

Related Procedures

Related Resources

Join DoveHubs

and connect with fellow professionals

Related Directories

Who we are

At DoveMed, our utmost priority is your well-being. We are an online medical resource dedicated to providing you with accurate and up-to-date information on a wide range of medical topics. But we're more than just an information hub - we genuinely care about your health journey. That's why we offer a variety of products tailored for both healthcare consumers and professionals, because we believe in empowering everyone involved in the care process.
Our mission is to create a user-friendly healthcare technology portal that helps you make better decisions about your overall health and well-being. We understand that navigating the complexities of healthcare can be overwhelming, so we strive to be a reliable and compassionate companion on your path to wellness.
As an impartial and trusted online resource, we connect healthcare seekers, physicians, and hospitals in a marketplace that promotes a higher quality, easy-to-use healthcare experience. You can trust that our content is unbiased and impartial, as it is trusted by physicians, researchers, and university professors around the globe. Importantly, we are not influenced or owned by any pharmaceutical, medical, or media companies. At DoveMed, we are a group of passionate individuals who deeply care about improving health and wellness for people everywhere. Your well-being is at the heart of everything we do.

© 2023 DoveMed. All rights reserved. It is not the intention of DoveMed to provide specific medical advice. DoveMed urges its users to consult a qualified healthcare professional for diagnosis and answers to their personal medical questions. Always call 911 (or your local emergency number) if you have a medical emergency!